Literature DB >> 29582049

Gene Therapy in Alzheimer Disease-It May Be Feasible, but Will It Be Beneficial?

Lawrence S Honig1,2,3.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 29582049     DOI: 10.1001/jamaneurol.2017.4029

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


× No keyword cloud information.
  4 in total

1.  Focused ultrasound delivery of a selective TrkA agonist rescues cholinergic function in a mouse model of Alzheimer's disease.

Authors:  K Xhima; K Markham-Coultes; H Nedev; S Heinen; H U Saragovi; K Hynynen; I Aubert
Journal:  Sci Adv       Date:  2020-01-22       Impact factor: 14.136

Review 2.  The Role of Chronic Inflammatory Bone and Joint Disorders in the Pathogenesis and Progression of Alzheimer's Disease.

Authors:  Robert A Culibrk; Mariah S Hahn
Journal:  Front Aging Neurosci       Date:  2020-12-07       Impact factor: 5.750

3.  Ultrasound delivery of a TrkA agonist confers neuroprotection to Alzheimer-associated pathologies.

Authors:  Kristiana Xhima; Kelly Markham-Coultes; Rikke Hahn Kofoed; H Uri Saragovi; Kullervo Hynynen; Isabelle Aubert
Journal:  Brain       Date:  2022-08-27       Impact factor: 15.255

4.  Intravenous and Non-invasive Drug Delivery to the Mouse Basal ForebrainUsing MRI-guided Focused Ultrasound.

Authors:  Kristiana Xhima; Dallan McMahon; Edward Ntiri; Maged Goubran; Kullervo Hynynen; Isabelle Aubert
Journal:  Bio Protoc       Date:  2021-06-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.